Abstract
The onychomycosis incidence was determined in 250 type 2 diabetes mellitus (T2DM) patients who were registered at the Internal Medicine Service from a Mexico city General Hospital throughout a year (January–December 2006). Out of the total of studied T2DM patients, 93 (37.2%) showed ungual dystrophy and from these, in 75.3% a fungal etiology was corroborated. Out of 70 patients, 34 were men and 36 women, with an average of 63.5 years. Correlation between T2DM evolution time and onychomycosis was significant (P < 0.01). Distal-lateral subungual and total dystrophic onychomycosis were the most frequent clinical types (55.1% and 33.7%, respectively). Fifty-eight fungal isolates were obtained; 48.6% corresponded to dermatophytes, Trichophyton rubrum being the first species (37.1%). All these strains corresponded to two morphological varieties: “yellow” and typical downy. From the yeast-like isolates, 12 corresponded to Candida spp., firstly C. albicans and C. parapsilosis; three to Cryptococcus spp. (C. albidus, C. uniguttulatus and C. laurentii); two Trichosporon asahii; and only one to Pichia ohmeri. Six non-dermatophytic molds were isolated: two Chrysosporium keratinophylus, two Scopulariopsis brevicaulis, one Aspergillus fumigatus, and one Acremonium sp. The fungal mixture corresponded to T. mentagrophytes with C. guilliermondii; T. mentagrophytes with C. glabrata; T. rubrum with C. glabrata; T. rubrum with P. ohmeri.
Similar content being viewed by others
References
Pardo-Costello V, Pardo OA. Diseases of the nails. Springfield, IL: Charles C. Thomas; 1960.
Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997;133:1172–3.
Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998;139:665–71.
Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994;30:519–51.
López González V, Mayorga J. Frecuencia de onicomicosis podal y tiña de los pies en 100 pacientes diabéticos tipo 2. Dermatología Rev Mex 2002;46:254–9.
Alvarez MI, González LA, Castro LA. Onychomycosis in Cali, Colombia. Mycopathologia 2004;158:181–6.
Ilkit M. Onychomycosis in Adana, Turkey: a 5-year study. Int J Dermatol 2005;44:851–4.
López-Martínez R, Hernández-Hernández F, Manzano-Gayosso P, Bazán-Mora E, Romero-Martínez R. Onicomicosis. Diagnóstico etiológico y frecuencia en 282 casos. Rev Mex Patol Clin 1994;41:56–9.
Baran R, Hay RJ, Tosti A, Haneke R. A new classification of onychomycosis. Br J Dermatol 1998;139:567–71.
Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003;149(Suppl 65):1–4.
Alteras I, Saryt E. Prevalence of pathogenic fungi in the webs and toenails of diabetic patients. Mycopathologia 1979;67:157–9.
Membreño Mann JP, Zonana Nacah A. Hospitalización de pacientes con diabetes mellitus. Causa, complicaciones y mortalidad. Rev Med IMSS 2005;43:97–101.
Kane J, Summerbell R, Sigler L, Krajden S, Land G. Laboratory handbook of dermatophytes. Belmont, USA: Star Publishing Company; 1997.
Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923–9.
Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species specific characteristic of Candida dubliniensis. Mycoses 1999;42:521–4.
Mosca CO, Moragues MD, Llovo J, AI Mosaid A, Coleman DC, Ponton J. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003;41:1259–62.
Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2004;42:4796–8.
Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-d-glucoside as determined with the API 20 C AUX and vitek YBC systems. J Clin Microbiol 1999;12:3804–8.
Rich P. Special patient populations: onychomycosis in the diabetic patients. J Am Acad Dermatol 1996;35(pt 2):S10–2.
Levy LA. Epidemiology of onychomycosis in special-risk populations. J Am Podiatr Med Assoc 1997;87:546–50.
McCarthy DJ, Boyko EJ, Smith DG. Cutaneous manifestations of the lower extremities in diabetes mellitus. In: Kominsky S, editor. Medical and surgical management of the diabetic foot. St. Louis: Mosby; 1994. p. 191–222.
Arenas R, Rubalcaba Priego J, Leyva Santiago J, Álvarez Zavala B, Fabian San Miguel G, Rubalcaba Priego MA, et al. Onicomicosis y diabetes mellitus tipo 2. Frecuencia en 143 pacientes ambulatorios. Dermatología Rev Mex 1999;43:1–7.
Piérard GE, Piérard-Franchimont C. The nail under fungal siege in patients with type II diabetes mellitus. Mycoses 2005;48:339–42.
Romano C, Gianni C, Difonzo EM. Retrospective study of onychomycosis in Italy: 1985–2000. Mycoses 2005;48:42–4.
Méndez-Tovar LJ, Anides-Fonseca A, Vázquez-Hernández A, Galindo-González M, Díaz-Madrid M, Berdón-Castro A, et al. Micosis observadas en cinco comunidades mexicanas con alto grado de marginación. Gac Méd Méx 2006;142:381–6.
Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis-a retrospective study. J Dtsch Dermatol Ges 2006;4:218–28.
Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42:217–24.
Gupta AK, Ryder JE, Baran R, Summerbell RC. Non-dermatophyte onychomycosis. Dermatol Clin 2003;21:257–68.
Acknowledgment
We wish to acknowledge Ricardo Orozco for his technical assistance in the translation of this document.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manzano-Gayosso, P., Hernández-Hernández, F., Méndez-Tovar, L.J. et al. Onychomycosis Incidence in Type 2 Diabetes Mellitus Patients. Mycopathologia 166, 41–45 (2008). https://doi.org/10.1007/s11046-008-9112-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-008-9112-5